Neonatal Exposure to Antibiotics Triggers Obesity in Adulthood by Permanent Microbiota Dysbiosis and Reduction of Adipose Regulatory T Cells
Barrier Immunity · 2026
DOI: 10.1002/dni2.70003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Barrier Immunity, 2026. Verfasst von Peter Zanvit und 18 weiteren Autor:innen. Beteiligte Einrichtung: Mucosal Immunology Section, National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health, Bethesda, Maryland, USA. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, National Institute of Dental and Craniofacial Research.
Abstract (Originalsprache)
Neonatal dysbiosis of the gut microbiota represents a critical environmental factor promoting obesity, but the underlying immunological mechanisms remain unknown. We show here that neonatal treatment of mice with broad‐spectrum antibiotics for the first 3 weeks of life (NeoATB) resulted in the development of obesity and metabolic abnormalities in adulthood. The NeoATB mice exhibited a permanent dysbiosis of gut microbiota, decreased CD4 + Foxp3 + regulatory T cells (Tregs), and increased proinflammatory Th1 cells in visceral adipose tissue (VAT). Mechanistically, neonatal antibiotic treatment resulted in increased intestinal permeability that allowed bacterial translocation into the VAT and liver and an increase in systemic LPS levels. Consequently, VAT CD11c + MHCII + cells were activated via the TLR4 pathway to increase IL‐12‐triggered Th1‐inflammation. Moreover, the decrease in VAT Tregs in NeoATB mice was attributed to reduced infiltration of Tregs from the periphery, decreased expansion of adipose IL‐33‐mediated ST2 + Tregs, and reduced conversion of local Tregs from VAT CD4 + CD25 − Foxp3 − T cells. Thus, we have revealed a previously unrecognized immunological link between neonatal microbiota dysbiosis and the development of obesity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mucosal Immunology Section, National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health, Bethesda, Maryland, USA.
- Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University, Chicago, Illinois, USA.
- Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
- Department of Transfusion Medicine, Center for Cellular Engineering, NIH, Bethesda, Maryland, USA.
- Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
- Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
ORCID-Profile: WanJun Chen
Förderung
- Intramural NIH HHS
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Zanvit, P., Xu, J., Yang, W., Guo, N., Yu, T., Jiao, X., Prochazkova, M., Jin, W., Liu, N., Park, S. A., Chia, C., Patel, D. P., Zhang, D., Goldberg, N., Cain, A., Gonzalez, F. J., Belkaid, Y., Cong, Y., & Chen, W. (2026). Neonatal Exposure to Antibiotics Triggers Obesity in Adulthood by Permanent Microbiota Dysbiosis and Reduction of Adipose Regulatory T Cells. Barrier Immunity. https://doi.org/10.1002/dni2.70003
Vancouver
Zanvit P, Xu J, Yang W, Guo N, Yu T, Jiao X, et al. Neonatal Exposure to Antibiotics Triggers Obesity in Adulthood by Permanent Microbiota Dysbiosis and Reduction of Adipose Regulatory T Cells. Barrier Immunity. 2026. doi:10.1002/dni2.70003
BibTeX
@article{Zanvit2026,
author = {Zanvit, Peter and Xu, Junji and Yang, Wenjing and Guo, Nancy and Yu, Tianming and Jiao, Xue and Prochazkova, Michaela and Jin, Wenwen and Liu, Na and Park, Sang-A and Chia, Cheryl and Patel, Daxesh P and Zhang, Dunfang and Goldberg, Nathan and Cain, Alexander and Gonzalez, Frank J and Belkaid, Yasmine and Cong, Yingzi and Chen, WanJun},
title = {Neonatal Exposure to Antibiotics Triggers Obesity in Adulthood by Permanent Microbiota Dysbiosis and Reduction of Adipose Regulatory T Cells},
journal = {Barrier Immunity},
year = {2026},
doi = {10.1002/dni2.70003}
}
EUVIMED